GL1X · GenesisL1 explorer

Research workbench

Crystal structure of inhibitor jnj-53718678 in complex with prefusion rsv F glycoprotein

Analyse Crystal structure of inhibitor jnj-53718678 in complex with prefusion rsv F… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5KWW
Type
protein
Length
428 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fusion glycoprotein F0, envelope glycoprotein chimera
UniProt
W8RJF9, M1E1E4
Ligands
6YA, NAG, SO4
Pockets
2 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
FFusion glycoprotein F0, envelope glycoprotein chimeraprotein42830% helix, 35% strandW8RJF9, M1E1E4

Ligands and binding sites

  • 6YA · 3-[[5-chloranyl-1-(3-methylsulfonylpropyl)indol-2-yl]methyl]-1-[2,2,2-tris(fluoranyl)ethyl]imidazo[4,5-c]pyridin-2-one · ligand · chains F
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains F
  • SO4 · Sulfate ion · ion · 10 copies · chains F
  • NHE · 2-[N-cyclohexylamino]ethane sulfonic acid · additive · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11400.450.7632empty
2690.310.7516SO4

Modifications

Observed in the structure: 7 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 5KWW · Crystal Structure of Inhibitor JNJ-53718678 In Complex with Prefusion RSV F Glycoprotein · the same entry in another collection · chain F against F, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.